PROVECTUS PHARMACEUTICALS INC 4

Accession 0001144204-07-050780

$PVCTCIK 0000315545operating

View on SEC.gov Company Profile

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 11:54 AM ET

Size

45.3 KB

Accession

0001144204-07-050780

Insider Transaction Report

Form 4

Period: 2006-06-08

PROVECTUS PHARMACEUTICALS INCPVCT

ADAMS DONALD E

10% Owner

Transactions

Sale
Common stock
2007-09-06$2.80/sh−50,000$140,000→ 5,551,123 total
Sale
Common stock
2006-08-11$1.13/sh−15,000$16,950→ 5,019,977 total
Sale
Common stock
2007-01-24$1.20/sh−1,500$1,800→ 5,004,477 total
Sale
Common stock
2007-03-19$1.24/sh−2,000$2,480→ 5,652,753 total
Sale
Common stock
2007-04-03$1.47/sh−4,000$5,880→ 5,646,753 total
Sale
Common stock
2007-02-23$1.14/sh−2,000$2,280→ 5,660,753 total
Sale
Common stock
2007-01-16$1.22/sh−6,000$7,320→ 5,013,977 total
Sale
Common stock
2007-01-22$1.20/sh−6,000$7,200→ 5,005,977 total
Sale
Common stock
2007-02-07$1.15/sh−4,772$5,488→ 5,672,753 total
Sale
Common stock
2007-03-07$1.15/sh−4,000$4,600→ 5,654,753 total
Purchase
Common stock
2007-01-27$1.05/sh+679,048$713,000→ 5,683,525 total
Sale
Common stock
2007-02-20$1.13/sh−2,000$2,260→ 5,662,753 total
Conversion
$382,250 8% Convertible Note
2006-06-08$0.74/sh+547,384$403,422→ 0 total
Exercise: $0.74From: 2005-11-26Exp: 2006-11-26→ Common Stock (547,384 underlying)
Sale
Common stock
2007-09-22$2.98/sh−5,000$14,900→ 5,526,123 total
Sale
Common stock
2007-02-06$1.13/sh−4,000$4,520→ 5,677,525 total
Sale
Common stock
2007-09-06$2.86/sh−5,000$14,300→ 5,546,123 total
Conversion
Common stock
2006-06-08$0.74/sh+518,657$382,250→ 5,006,250 total
Sale
Common stock
2007-04-11$1.45/sh−630$914→ 5,646,123 total
Sale
Common stock
2007-01-17$1.23/sh−2,000$2,460→ 5,011,977 total
Sale
Common stock
2007-01-31$1.17/sh−2,000$2,340→ 5,681,525 total
Sale
Common stock
2007-02-13$1.12/sh−8,000$8,960→ 5,664,753 total
Sale
Common stock
2007-03-02$1.14/sh−2,000$2,280→ 5,658,753 total
Sale
Common stock
2007-03-21$1.29/sh−2,000$2,580→ 5,650,753 total
Sale
Common stock
2007-09-04$2.08/sh−20,000$41,500→ 5,626,123 total
Conversion
Common stock
2006-06-08+28,727→ 5,034,977 total
Sale
Common stock
2007-09-05$2.40/sh−25,000$60,000→ 5,601,123 total

Footnotes (6)

[F1]Issued upon the conversion of an 8% Convertible Note in the principal amount of $382,250 reported on Form 3, dated March 29, 2006, at a conversion price of $0.737 per share.
[F2]Shares received in satisfaction of accrued and unpaid interest of Convertible Note described above.
[F3]Shares purchased in a Private Placement under Regulation D of the Securities Act of 1933, as amended.
[F4]Convertible Note was convertible into shares of Common Stock at any time at the sole discretion of the Reporting Person.
[F5]Does not include (i) 1,116,667 shares of Common Stock issuable upon the exercise of a warrant at a purchase price of $0.935 per share and expiring on December 31, 2010 and (ii) 533,333 shares of Common Stock issuable upon the exercise of a warrant at a purchase price of $0.99per share and expiring on March 30, 2010.
[F6]Consists of (i) 518,657 shares of Common Stock issued upon the conversion of the principal amount of the Convertible Note and (ii) 28,727 shares of Common Stock issued in satisfaction of accrued and unpaid interest on the Convertible Note.

Documents

1 file

4
v087678_ex.xmlPrimary

Issuer

PROVECTUS PHARMACEUTICALS INC

CIK 0000315545

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000315545

Filing Metadata

Form type: 4
Filed: Sep 23, 8:00 PM ET
Accepted: Sep 24, 11:54 AM ET
Size: 45.3 KB

View on SEC.gov